SMTL ID : 8coe.1

complement C5 in complex with the LCP0195 nanobody

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 4.20 Å

Oligo State

hetero-1-1-1-mer

Ligands

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.1: 4 residues within 4Å: Chain B: N.232, N.234, I.245, V.247 2 PLIP interactions: 2 interactions with chain B Hydrophobic interactions: B:I.245 Hydrogen bonds: B:N.232

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Jindal, S. et al., Characterization of the bispecific VHH antibody gefurulimab (ALXN1720) targeting complement component 5, and designed for low volume subcutaneous administration. Mol.Immunol. (2023)

Release Date

2024-01-03

Peptides

Complement C5 beta chain: A
Complement C5 alpha chain: B
LCP0195: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
A

C
B

Complement C5 beta chain

Complement C5 alpha chain

LCP0195

Related Entries With Identical Sequence